Abstract: A therapeutic pharmaceutical composition for the treatment of respiratory disease is disclosed, including particularly Respiratory Distress Syndrome (RDS). The composition is comprised of a synthetic dimer of an N-terminal fragment of Surfactant Protein B (SP-B) that advantageously mimics the functional activity of native human Surfactant Protein B, and to therapeutic methods of administration of such pharmaceutical compositions.

Abstract: A storage enclosure includes a base including a top panel extending transversely from a front panel. The base is attachable to a load deck of an open deck vehicle such that an enclosed space is defined by the front and top panels and the load deck. The base includes mounts within the enclosed space that are attachable to a bracket for attaching the base to the load deck. The top panel includes side portions that extend from opposite ends of the front panel, and a removable cover panel is disposed between the side portions. A cage is mounted to the base that defines a cage compartment above the top panel. The cage includes legs that extend through the base and are engaged by locking elements to removably secure the cage to the base. The cage includes frame segments that are releasably connected to one another by release pins.

Abstract: The present invention solves the need for non-toxic forms of selenium which is an essential part of the human diet. This invention provides novel dried-yeast products containing selenium as well as a method of producing the dried yeast products. The method uses selenium having high biological activity but low toxicity. The invention also provides nutritional supplements containing the novel selenium containing dried yeast products and methods of administering these products and supplements to improve human health. The invention also provides a practically non-toxic yeast selenium product having increased intracellular selenium concentrations and methods to reduce tumor cell growth by administration of a selenium yeast product in combination with chemotherapeutic agents. In particular, selenium yeast product of strain ATCC 74366.

Abstract: The present invention relates to a dietary supplement for the treatment of obesity, including both weight loss and reduction of weight gain. Pursuant to the invention, a decoction of a herbal mixture, comprising rhubarb, red saga root, astragalus, turmeric, and dried ginger and various combinations thereof, provides therapeutic weight loss as well as lipid reduction and change body composition. The invention includes methods of manufacture and administration and also includes the herbal decoction in various forms of administration and in combination with food.